Steven Cohen's WVE Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 1.48 M shares of Wave Life Sciences, Inc. (WVE) worth $8.63 M, representing 0.01% of the portfolio. First purchased in 2017-Q3, this long-term strategic position has been held for 27 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in WVE, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2023, adding 3.21 M shares. Largest reduction occurred in Q2 2024, reducing 1.86 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Wave Life Sciences (WVE) Holding Value Over Time
Track share changes against reported price movement
Quarterly Wave Life Sciences (WVE) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +1.48 M | New Buy | 1.48 M | $5.81 |
| Q4 2025 | -663,967 | Sold Out | 0 | $0.00 |
| Q3 2025 | +663,967 | New Buy | 663,967 | $7.32 |
| Q4 2024 | -28,096 | Sold Out | 0 | $0.00 |
| Q3 2024 | -87,382 | Reduce 75.67% | 28,096 | $8.20 |
| Q2 2024 | -1.86 M | Reduce 94.15% | 115,478 | $4.99 |
| Q1 2024 | -1.24 M | Reduce 38.55% | 1.97 M | $6.17 |
| Q4 2023 | +3.21 M | New Buy | 3.21 M | $5.05 |
| Q2 2023 | -15,800 | Sold Out | 0 | $0.00 |
| Q1 2023 | -47,800 | Reduce 75.16% | 15,800 | $4.33 |
| Q4 2022 | -970,600 | Reduce 93.85% | 63,600 | $7.00 |
| Q3 2022 | +1.03 M | New Buy | 1.03 M | $3.61 |
| Q2 2021 | -849,109 | Sold Out | 0 | $0.00 |
| Q1 2021 | +849,109 | New Buy | 849,109 | $5.61 |
| Q3 2020 | -286,116 | Sold Out | 0 | $0.00 |
| Q2 2020 | +286,116 | New Buy | 286,116 | $10.41 |
| Q1 2020 | -158,400 | Sold Out | 0 | $0.00 |
| Q4 2019 | +113,400 | Add 252.00% | 158,400 | $8.02 |
| Q3 2019 | +1,500 | Add 3.45% | 45,000 | $20.53 |
| Q2 2019 | -538,811 | Reduce 92.53% | 43,500 | $26.09 |
| Q1 2019 | +92,499 | Add 18.88% | 582,311 | $38.85 |
| Q4 2018 | +89,812 | Add 22.45% | 489,812 | $42.04 |
| Q3 2018 | +50,000 | Add 14.29% | 400,000 | $50.00 |
| Q2 2018 | +307,700 | Add 727.42% | 350,000 | $38.25 |
| Q1 2018 | -57,700 | Reduce 57.70% | 42,300 | $40.09 |
| Q4 2017 | -528,912 | Reduce 84.10% | 100,000 | $35.10 |
| Q3 2017 | +628,912 | New Buy | 628,912 | $21.75 |
Steven Cohen's Wave Life Sciences Investment FAQs
Steven Cohen first purchased Wave Life Sciences, Inc. (WVE) in Q3 2017, acquiring 628,912 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Wave Life Sciences, Inc. (WVE) for 27 quarters since Q3 2017.
Steven Cohen's largest addition to Wave Life Sciences, Inc. (WVE) was in Q4 2023, adding 3,213,500 shares worth $16.23 M.
According to the latest 13F filing for Q2 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 1,484,989 shares of Wave Life Sciences, Inc. (WVE), valued at approximately $8.63 M.
As of the Q2 2026 filing, Wave Life Sciences, Inc. (WVE) represents approximately 0.01% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Wave Life Sciences, Inc. (WVE) was 3,213,500 shares, as reported at the end of Q4 2023.